Importantly, it's secretion from normal cells can be induced by activating p53 so that Par - 4 enters circulation, thereby potentially targeting tumor
cells at distant sites.
Not exact matches
When the dendritic
cells are activated, they train T
cells — their allies in the adaptive arm of the immune system — to attack cancer
cells anywhere in the body, whether
at the
site of the original tumor or
distant metastases.
Studies in cancer patients indicate reduced rates of relapse when patients are pretreated with epigenetic drugs due to its far - reaching capabilities; killing progenitor
cells at the
site of the tumor, in circulation, or
at a
distant site.
Eventually some tumor
cells may break off and establish new growths (metastases)
at distant sites.
«The recent discovery of tumor - promoting milieus, referred to as metastatic niches, that are established
at distant sites prior to or upon the arrival of disseminated tumor
cells could explain cancer
cells that relapse early, but in late relapsing populations, what tumor
cells do from the time of dissemination to the time they become clinically detectable has been a big question.»
We describe an experimental model system that definitively links surgery and the subsequent wound - healing response to the outgrowth of tumor
cells at distant anatomical
sites.
This allows cancer
cells to break off from tumors, spread throughout the body (in blood or other fluid) and form new tumors
at distant sites — a process called metastasis.
The therapy not only killed
cells at the primary tumor
site, but also in
distant metastases by «bystander» antitumor activity driven by the secreted MDA - 7 / IL - 24 protein.
The prognosis for metastatic cancer (also called stage IV cancer) is generally poor, so a technique that could detect these circulating tumor
cells before they have a chance to form new colonies of tumors
at distant sites could greatly increase a patient's survival odds.
With PTHLH, the
cells that have colonized the liver are armed with a system that facilitate their activity
at a
distant site and they are able to prepare a niche in which to generate a new lung lesion.
The Ludwig Center
at the University of Chicago --- under the direction of Ralph Weichselbaum, MD, the Daniel K. Ludwig Professor and Chair of the Department of Radiation and Cellular Oncology, and Geoffrey Greene, PhD, the Daniel K. Ludwig Professor in the Ben May Cancer Research Institute
at the University of Chicago — will focus on metastasis, the process by which cancer
cells migrate from a primary tumor to multiple
distant sites.
This multi-stage process requires tumour
cells to survive in the circulation, extravasate
at distant sites, then proliferate; it involves contributions from both the tumour
cell and tumour microenvironment («host», which includes stromal
cells and the immune system).